Table 3.
Statistical comparison (Wilcoxon's signed rank test) of the microbiological effects between the treatment modalities after 42 days (values are given as mean (SD) CFU/ml×10e4).
| Group | Reduction | Group | Reduction | Significance |
|---|---|---|---|---|
| Aa | ||||
| SRP+Prodentis | 94.0 (62.8) | SRP+placebo | 6.4 (75.7) | p<0.005 |
| SRP+Prodentis | 94.0 (62.8) | Prodentis | 74.7 (67.9) | ns |
| SRP+placebo | 6.4 (75.7) | Placebo | 10.0 (21.0) | ns |
| Prodentis | 74.7 (67.9) | Placebo | 10.0 (21.0) | p<0.01 |
| Pg | ||||
| SRP+Prodentis | 85.7 (73.5) | SRP+placebo | 0.4 (46.4) | p<0.005 |
| SRP+Prodentis | 85.7 (73.5) | Prodentis | 91.3 (51.7) | ns |
| SRP+placebo | 0.4 (46.4) | Placebo | −6.8 (32.3) | ns |
| Prodentis | 91.3 (51.7) | Placebo | −6.8 (32.3) | p<0.001 |
| Pi | ||||
| SRP+Prodentis | 77.0 (65.1) | SRP+placebo | 6.4 (67.9) | p<0.05 |
| SRP+Prodentis | 77.0 (65.1) | Prodentis | 71.0 (63.6) | ns |
| SRP+placebo | 6.4 (67.9) | Placebo | −16.4 (69.2) | ns |
| Prodentis | 71.0 (63.6) | Placebo | −16.4 (69.2) | p<0.001 |